Swiss (SMI) Pharmaceuticals & Biotech Stocks - Top Gainers Today

Company	Last Price	1D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
LONN Lonza Group	CHF 554.40	1.2%	48.7%	CHF 40.0b	CHF 638.15	PE69.9x	E21.0%	0.7%
SKAN SKAN Group	CHF 78.30	3.8%	-1.4%	CHF 1.8b	CHF 90.67	PE54.6x	E17.8%	0.4%
DESN Dottikon ES Holding	CHF 215.00	1.7%	1.4%	CHF 3.0b	CHF 350.00	PE39.3x	S16.4%	0%
SFZN Siegfried Holding	CHF 983.00	0.9%	13.5%	CHF 4.2b	CHF 1,167.67	PE32.7x	E13.0%	0.4%
BANB Bachem Holding	CHF 56.10	0.4%	-0.6%	CHF 4.2b	CHF 76.86	PE37x	E17.8%	1.4%
CURN Curatis Holding	CHF 14.30	1.8%	n/a	CHF 69.3m	CHF 20.00	n/a	n/a	n/a
RLF Relief Therapeutics Holding	CHF 3.90	2.1%	140.7%	CHF 48.9m	n/a	PS5.7x	n/a	n/a
ADXN Addex Therapeutics	CHF 0.061	-2.9%	12.5%	CHF 6.0m	n/a	PS10.2x	E18.5%	n/a
SPEX Spexis	CHF 0.02	-55.6%	-96.4%	CHF 1.4m	n/a	PS2.3x	n/a	n/a
SANN Santhera Pharmaceuticals Holding	CHF 14.00	-0.7%	41.1%	CHF 175.2m	CHF 25.00	PE2.8x	S-74.4%	n/a
NWRN Newron Pharmaceuticals	CHF 8.89	-1.1%	13.4%	CHF 177.4m	CHF 13.71	PS27.1x	E42.8%	n/a
XLS Xlife Sciences	CHF 24.40	-2.0%	-47.4%	CHF 140.1m	n/a	PE6.6x	n/a	n/a
IDIA Idorsia	CHF 0.77	-3.4%	-47.1%	CHF 144.3m	CHF 1.00	PS1.9x	E17.4%	n/a
MOLN Molecular Partners	CHF 4.75	-4.7%	18.9%	CHF 174.9m	CHF 9.75	PS29.1x	E10.2%	n/a
COPN Cosmo Pharmaceuticals	CHF 63.80	-0.9%	3.9%	CHF 1.0b	CHF 98.37	PE15.6x	E21.5%	2.9%
BSLN Basilea Pharmaceutica	CHF 40.30	-2.9%	20.3%	CHF 488.5m	CHF 77.25	PS3.3x	E14.9%	0%
PPGN PolyPeptide Group	CHF 24.35	-2.0%	67.9%	CHF 803.2m	CHF 34.72	PS2.6x	E64.9%	0%
TECN Tecan Group	CHF 224.00	-0.7%	-30.5%	CHF 2.9b	CHF 283.83	PE28.4x	E14.7%	1.3%
KURN Kuros Biosciences	CHF 22.20	-4.5%	410.3%	CHF 840.3m	n/a	PS16x	n/a	n/a
SDZ Sandoz Group	CHF 40.77	-0.7%	39.9%	CHF 17.9b	CHF 44.38	PS1.9x	E29.7%	1.1%
GALD Galderma Group	CHF 108.70	-0.6%	n/a	CHF 25.8b	CHF 101.82	PS6.5x	E36.4%	n/a
NOVN Novartis	CHF 89.32	-1.4%	-5.4%	CHF 178.6b	CHF 103.51	PE16.6x	E7.0%	3.7%
ROG Roche Holding	CHF 265.40	-1.2%	7.1%	CHF 213.6b	CHF 303.47	PE19.9x	E10.2%	3.6%